Malignant Hypertension: Causes, Symptoms, and Urgent Treatment

Malignant hypertension is a critical form of high blood pressure characterized by a sudden and extreme elevation in blood pressure, often exceeding 180/120 mmHg. This condition can lead to acute damage in vital organs, including the heart, kidneys, brain, and eyes. It is a medical emergency that requires immediate intervention to prevent permanent organ damage or death. Without prompt treatment, malignant hypertension can lead to life-threatening complications such as heart failure, kidney failure, stroke, and vision loss.

The causes of malignant hypertension are varied and include uncontrolled chronic hypertension, kidney disorders, adrenal gland tumors (such as pheochromocytoma), and certain medications like oral contraceptives, corticosteroids, or non-steroidal anti-inflammatory drugs. Uncontrolled chronic hypertension, in particular, predisposes individuals to the condition as it causes damage to the blood vessels, making them more susceptible to sudden pressure surges. Kidney disorders, such as glomerulonephritis or renal artery stenosis, also contribute, as the kidneys play a crucial role in regulating blood pressure. Adrenal gland tumors cause excessive production of hormones that can lead to dangerous spikes in blood pressure.

Symptoms of malignant hypertension are severe and can include intense headaches, blurred vision, chest pain, shortness of breath, and neurological signs such as confusion or seizures. These symptoms arise due to the rapid increase in pressure, which can cause blood vessels to rupture or leak, leading to organ damage. For instance, brain blood vessel damage can cause swelling, resulting in encephalopathy, which leads to confusion, seizures, or coma.

Diagnosis of malignant hypertension involves immediate blood pressure measurement and tests to assess organ damage. Blood tests, imaging studies like CT or MRI, and electrocardiograms (ECG) are commonly used. Treatment focuses on carefully reducing blood pressure with intravenous medications like nitroprusside or labetalol, followed by oral medications to maintain stability. Long-term care involves treating the underlying cause and lifestyle changes, such as a low-sodium diet and regular exercise.

Prompt recognition and swift treatment are essential to prevent severe complications, improve survival rates, and reduce the risk of long-term organ damage. Regular monitoring and addressing risk factors play a key role in managing and preventing malignant hypertension from recurring.
Malignant Hypertension: Causes, Symptoms, and Urgent Treatment

Symptoms of malignant hypertension

Malignant hypertension is a rare syndrome consisting of rapid and severe elevation of blood pressure, with then systolic component above 200 mmHg or the diastolic blood pressure greater than 140 mmHg.

Sign and symptoms of malignant hypertension include neurological changes such as anxiety, confusion, lethargy, numbness, tingling or weakness in the extremism and seizures.

The most common presentations include headaches and visual disturbances, chest pain, and dyspnea.

Other possible symptoms include nausea, vomiting and decreased urine production. Cardiac symptoms such as angina, myocardial infarction and pulmonary oedema my occasionally be the main presenting symptoms.

Malignant hypertension causes target organ damage, particularly to the kidney. The patient is likely in renal failure, indicated by the elevation in blood urea nitrogen and creatinine, the lack of urine production and the metabolite acidosis.

Persistent elevated malignant hypertension can lead to rapidly fatal course, with heart failure, myocardial infarction stroke or renal failure.
Symptoms of malignant hypertension

Malignant hypertension

Malignant hypertension is a clinical syndrome characterized by a marked elevation of BP with widespread acute arteriolar injury. It is associated with very high blood pressures and vascular injury.

The term malignant hypertension was first used by Volhard and Farh in 1914 after noting that many patients with severe hypertension had fundoscopic changes such as retinopathy and papilledema in addition to renal insufficiency.

They defined malignant hypertension as an elevated blood pressure with signs of acute end-organ damage.

Malignant hypertension displays severe arterial changes such as concentric onion skin lesion and thickening of the intima by smooth muscle cells and fibroblasts, so called hyperplastic endoarteritis.

The vascular injury is characterized by fibrinoid necrosis and proliferative endarteritis. It is a hypotensive emergency associated with ischemic retinal changes consistent with grades III or IV hypertensive retinopathy.

If malignant hypertension is left untreated, around 8 percent of patients die within 2 years, hence the name.

The importance of early diagnosis is emphasized as patients tend to develop clinical symptoms only at a late stage of their disease.
Malignant hypertension